DRIVE Influenza Point of Care Testing Study 2019/2020
DRIVE is a public private partnership that advances European cooperation in influenza vaccine effectiveness studies. It seeks to establish a sufficiently sized network for robust, high quality, brand-specific effectiveness estimates for all influenza vaccines used in the EU each season. The data generated through DRIVE is expected to increase the understanding of influenza vaccine effectiveness, lead to enhanced monitoring of influenza vaccine performance by public health institutes and allow manufacturers to fulfil regulatory requirements. DRIVE also aims to develop a sustainable and transparent governance model for public private partnerships.
We are conducting the POCT study during the 2019/2020 flu season involving 12 practices across England.
DRIVE Weekly Return 2019/2020
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 777363. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
